Abstract
Background: Randomized clinical trials have shown that multivessel coronary angioplasty is feasible and provides similar long-term survival as bypass surgery in selected patients. However, the higher need for repeat intervention, in particular, coronary artery bypass graft surgery, remains a problem. The objective of this study was to test the hypothesis that multivessel stenting is safe and effective in reducing the need for repeat interventions, in particular, the need for bypass surgery. Meritotis and Results: Between March 1993 and June 1995. 100 consecutive patients (243 lesions) had multivessel coronary stenting. High-pressure stent optimization was used in all patients. Procedural success was achieved in 97% of lesions: 2 patients (2%) required emergency bypass surgery. Angiographic follow-up was obtained in 89% of patients at 5.2±2.5 months. Angiographic restenosis occurred in 22% of the lesions, but 37% of patients had ≤1 lesion with restenosis Clinical follow-up was obtained in all patients at 21±10 months: target lesion revascularization was needed in 30 patients (30%), repeat angioplasty in 28 patients (28%), and coronary bypass surgery in 2 patients (2%); the overall survival rate was 96% (2% noncardiac death). Conclusions: Multivessel coronary stenting can be performed with high success rate and low need for emergency bypass surgery. Compared with historical results with multivessel percutaneous transluminal coronary angioplasty, patients who undergo multivessel stenting need less repeat interventions, in particular, less coronary bypass surgery and have similar long-term survival.
| Original language | English |
|---|---|
| Pages (from-to) | 3873-3879 |
| Number of pages | 7 |
| Journal | Circulation |
| Volume | 96 |
| Issue number | 11 |
| Publication status | Published - 1997 |
Fingerprint
Keywords
- Angioplasty
- Follow-up studies
- Revascularization
- Stents
ASJC Scopus subject areas
- Physiology
- Cardiology and Cardiovascular Medicine
Cite this
Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. / Moussa, Issam; Reimers, Bernhard; Moses, Jeffrey; Di Mario, Carlo; Lucia Di, Francesco; Ferraro, Massimo; Colombo, Antonio.
In: Circulation, Vol. 96, No. 11, 1997, p. 3873-3879.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting
AU - Moussa, Issam
AU - Reimers, Bernhard
AU - Moses, Jeffrey
AU - Di Mario, Carlo
AU - Lucia Di, Francesco
AU - Ferraro, Massimo
AU - Colombo, Antonio
PY - 1997
Y1 - 1997
N2 - Background: Randomized clinical trials have shown that multivessel coronary angioplasty is feasible and provides similar long-term survival as bypass surgery in selected patients. However, the higher need for repeat intervention, in particular, coronary artery bypass graft surgery, remains a problem. The objective of this study was to test the hypothesis that multivessel stenting is safe and effective in reducing the need for repeat interventions, in particular, the need for bypass surgery. Meritotis and Results: Between March 1993 and June 1995. 100 consecutive patients (243 lesions) had multivessel coronary stenting. High-pressure stent optimization was used in all patients. Procedural success was achieved in 97% of lesions: 2 patients (2%) required emergency bypass surgery. Angiographic follow-up was obtained in 89% of patients at 5.2±2.5 months. Angiographic restenosis occurred in 22% of the lesions, but 37% of patients had ≤1 lesion with restenosis Clinical follow-up was obtained in all patients at 21±10 months: target lesion revascularization was needed in 30 patients (30%), repeat angioplasty in 28 patients (28%), and coronary bypass surgery in 2 patients (2%); the overall survival rate was 96% (2% noncardiac death). Conclusions: Multivessel coronary stenting can be performed with high success rate and low need for emergency bypass surgery. Compared with historical results with multivessel percutaneous transluminal coronary angioplasty, patients who undergo multivessel stenting need less repeat interventions, in particular, less coronary bypass surgery and have similar long-term survival.
AB - Background: Randomized clinical trials have shown that multivessel coronary angioplasty is feasible and provides similar long-term survival as bypass surgery in selected patients. However, the higher need for repeat intervention, in particular, coronary artery bypass graft surgery, remains a problem. The objective of this study was to test the hypothesis that multivessel stenting is safe and effective in reducing the need for repeat interventions, in particular, the need for bypass surgery. Meritotis and Results: Between March 1993 and June 1995. 100 consecutive patients (243 lesions) had multivessel coronary stenting. High-pressure stent optimization was used in all patients. Procedural success was achieved in 97% of lesions: 2 patients (2%) required emergency bypass surgery. Angiographic follow-up was obtained in 89% of patients at 5.2±2.5 months. Angiographic restenosis occurred in 22% of the lesions, but 37% of patients had ≤1 lesion with restenosis Clinical follow-up was obtained in all patients at 21±10 months: target lesion revascularization was needed in 30 patients (30%), repeat angioplasty in 28 patients (28%), and coronary bypass surgery in 2 patients (2%); the overall survival rate was 96% (2% noncardiac death). Conclusions: Multivessel coronary stenting can be performed with high success rate and low need for emergency bypass surgery. Compared with historical results with multivessel percutaneous transluminal coronary angioplasty, patients who undergo multivessel stenting need less repeat interventions, in particular, less coronary bypass surgery and have similar long-term survival.
KW - Angioplasty
KW - Follow-up studies
KW - Revascularization
KW - Stents
UR - http://www.scopus.com/inward/record.url?scp=0030679591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030679591&partnerID=8YFLogxK
M3 - Article
VL - 96
SP - 3873
EP - 3879
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 11
ER -